Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Erratum: Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.

Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J, Sünderhauf A, Softic S, Kahn CR, Stemmer K, Iwakura Y, Aronow BJ, Karns R, Steinbrecher KA, Karp CL, Sheridan R, Shanmukhappa SK, Reynaud D, Haslam DB, Sina C, Rupp J, Hogan SP, Divanovic S.

Nat Med. 2017 Oct 6;23(10):1241. doi: 10.1038/nm1017-1241c.

PMID:
28985207
2.

Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.

Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J, Sünderhauf A, Softic S, Kahn CR, Stemmer K, Iwakura Y, Aronow BJ, Karns R, Steinbrecher KA, Karp CL, Sheridan R, Shanmukhappa SK, Reynaud D, Haslam DB, Sina C, Rupp J, Hogan SP, Divanovic S.

Nat Med. 2017 Jul;23(7):829-838. doi: 10.1038/nm.4346. Epub 2017 Jun 12. Erratum in: Nat Med. 2017 Oct 6;23 (10 ):1241.

3.

Myeloid-derived NF-κB negative regulation of PU.1 and c/EBP-β-driven pro-inflammatory cytokine production restrains LPS-induced shock.

Vanoni S, Tsai YT, Waddell A, Waggoner L, Klarquist J, Divanovic S, Hoebe K, Steinbrecher KA, Hogan SP.

Innate Immun. 2017 Feb;23(2):175-187. doi: 10.1177/1753425916681444. Epub 2016 Dec 8.

4.

Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.

Klarquist J, Tobin K, Farhangi Oskuei P, Henning SW, Fernandez MF, Dellacecca ER, Navarro FC, Eby JM, Chatterjee S, Mehrotra S, Clark JI, Le Poole IC.

Cancer Res. 2016 Nov 1;76(21):6230-6240. Epub 2016 Sep 12.

5.

Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice.

Eby JM, Barse L, Henning SW, Rabelink MJ, Klarquist J, Gilbert ER, Hammer AM, Fernandez MF, Yung N, Khan S, Miller HG, Kessler ER, Garrett-Mayer E, Dilling DF, Hoeben RC, Le Poole IC.

Cancer Immunol Immunother. 2017 Jan;66(1):63-75. doi: 10.1007/s00262-016-1920-8. Epub 2016 Oct 27.

PMID:
27787577
6.

Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.

Klarquist J, Zhou Z, Shen N, Janssen EM.

Mediators Inflamm. 2016;2016:5045248. doi: 10.1155/2016/5045248. Epub 2016 Mar 30. Review.

7.

Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.

Klarquist J, Eby JM, Henning SW, Li M, Wainwright DA, Westerhof W, Luiten RM, Nishimura MI, Le Poole IC.

Pigment Cell Melanoma Res. 2016 May;29(3):379-84. doi: 10.1111/pcmr.12458. Epub 2016 Mar 4.

PMID:
26824221
8.

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice.

Klarquist J, Janssen EM.

J Vis Exp. 2015 Nov 1;(105):e53319. doi: 10.3791/53319.

9.

Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.

Legein B, Janssen EM, Theelen TL, Gijbels MJ, Walraven J, Klarquist JS, Hennies CM, Wouters K, Seijkens TT, Wijnands E, Sluimer JC, Lutgens E, Zenke M, Hildner K, Biessen EA, Temmerman L.

Sci Rep. 2015 Oct 21;5:15414. doi: 10.1038/srep15414.

10.

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.

Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM.

J Immunol. 2014 Dec 15;193(12):6124-34. doi: 10.4049/jimmunol.1401869. Epub 2014 Nov 10.

11.

Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Eby JM, Kang HK, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, Garrett-Mayer E, Longley BJ, Engelhard VH, Mehrotra S, Le Poole IC.

Pigment Cell Melanoma Res. 2014 Nov;27(6):1075-85. doi: 10.1111/pcmr.12284. Epub 2014 Jul 21.

12.

Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.

Mosenson JA, Flood K, Klarquist J, Eby JM, Koshoffer A, Boissy RE, Overbeck A, Tung RC, Le Poole IC.

Pigment Cell Melanoma Res. 2014 Mar;27(2):209-20. doi: 10.1111/pcmr.12208. Epub 2014 Jan 13.

13.

Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.

Gilbert ER, Eby JM, Hammer AM, Klarquist J, Christensen DG, Barfuss AJ, Boissy RE, Picken MM, Love RB, Dilling DF, Le Poole IC.

Am J Pathol. 2013 Jul;183(1):226-34. doi: 10.1016/j.ajpath.2013.04.002. Epub 2013 May 10. Erratum in: Am J Pathol. 2013 Nov;183(5):1698.

PMID:
23665200
14.

Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Klarquist JS, Janssen EM.

Oncoimmunology. 2012 Dec 1;1(9):1584-1593.

15.

A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.

Mehrotra S, Al-Khami AA, Klarquist J, Husain S, Naga O, Eby JM, Murali AK, Lyons GE, Li M, Spivey ND, Norell H, Martins da Palma T, Onicescu G, Diaz-Montero CM, Garrett-Mayer E, Cole DJ, Le Poole IC, Nishimura MI.

J Immunol. 2012 Aug 15;189(4):1627-38. doi: 10.4049/jimmunol.1103271. Epub 2012 Jul 13.

16.

HSP70i is a critical component of the immune response leading to vitiligo.

Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Poole IC.

Pigment Cell Melanoma Res. 2012 Jan;25(1):88-98. doi: 10.1111/j.1755-148X.2011.00916.x. Epub 2011 Nov 14.

17.

Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.

Elassiuty YE, Klarquist J, Speiser J, Yousef RM, El Refaee AA, Hunter NS, Shaker OG, Gundeti M, Nieuweboer-Krobotova L, Le Poole IC.

Exp Dermatol. 2011 Jun;20(6):496-501. doi: 10.1111/j.1600-0625.2010.01232.x. Epub 2011 Mar 22.

18.

Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.

Hariharan V, Toole T, Klarquist J, Mosenson J, Longley BJ, Le Poole IC.

Melanoma Res. 2011 Apr;21(2):115-26. doi: 10.1097/CMR.0b013e328343f542.

19.

Reduced skin homing by functional Treg in vitiligo.

Klarquist J, Denman CJ, Hernandez C, Wainwright DA, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC.

Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86. doi: 10.1111/j.1755-148X.2010.00688.x. Epub 2010 Feb 19. Erratum in: Pigment Cell Melanoma Res. 2010 Jun;23(3):477. Wainwright, Derek J [corrected to Wainwright, Derek A].

20.

Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, Dilling DF, McKee MD, Boissy RE, Love RB, Nishimura MI, Le Poole IC.

Am J Pathol. 2009 Dec;175(6):2463-72. doi: 10.2353/ajpath.2009.090525. Epub 2009 Nov 5.

21.

Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.

Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC.

J Invest Dermatol. 2010 Jan;130(1):211-20. doi: 10.1038/jid.2009.214.

22.

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.

Burton JR Jr, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR; Virahep-C Study Group.

J Hepatol. 2008 Sep;49(3):329-38. doi: 10.1016/j.jhep.2008.05.020. Epub 2008 Jun 23.

PMID:
18644644
23.

HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

Denman CJ, McCracken J, Hariharan V, Klarquist J, Oyarbide-Valencia K, Guevara-Patiño JA, Le Poole IC.

J Invest Dermatol. 2008 Aug;128(8):2041-8. doi: 10.1038/jid.2008.45. Epub 2008 Mar 13.

25.

Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.

Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR Jr, Tester IA, Wang CC, Culbertson N, Vandenbark AA, Rosen HR.

J Infect Dis. 2008 Jan 1;197(1):46-57. doi: 10.1086/523651.

PMID:
18171284
26.

Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.

Smyk-Pearson S, Tester IA, Klarquist J, Palmer BE, Pawlotsky JM, Golden-Mason L, Rosen HR.

J Virol. 2008 Feb;82(4):1827-37. Epub 2007 Nov 28.

27.

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR.

J Infect Dis. 2007 Nov 15;196(10):1474-82. Epub 2007 Oct 31.

PMID:
18008226
28.

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.

Rosen HR, Weston SJ, Im K, Yang H, Burton JR Jr, Erlich H, Klarquist J, Belle SH; Virahep-C Study Group.

Hepatology. 2007 Aug;46(2):350-8.

PMID:
17659573
29.

Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.

Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR.

J Virol. 2007 Sep;81(17):9249-58. Epub 2007 Jun 13.

30.

Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.

Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, Wang C, Rosen HR.

Hepatology. 2006 Nov;44(5):1098-109.

PMID:
17058243

Supplemental Content

Loading ...
Support Center